Sio Capital Management LLC 13D and 13G filings for Aprea Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-12 08:00 am Sale | 2025-09-30 | 13G | Aprea Therapeutics, Inc. APRE | Sio Capital Management LLC | 112,223 1.930% | -167,146 (-59.83%) | Filing |
| 2025-08-13 2:00 pm Purchase | 2025-06-30 | 13G | Aprea Therapeutics, Inc. APRE | Sio Capital Management LLC | 279,369 5.050% | 2,766 (+1.00%) | Filing |
| 2025-04-08 3:14 pm Sale | 2025-03-31 | 13G | Aprea Therapeutics, Inc. APRE | Sio Capital Management LLC | 276,603 5.040% | -3,397 (-1.21%) | Filing |
| 2024-02-14 08:00 am Purchase | 2023-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Sio Capital Management LLC | 280,000 7.490% | 280,000 (New Position) | Filing |